JAC Advance Access originally published online on November 16, 2007
Journal of Antimicrobial Chemotherapy 2008 61(1):219; doi:10.1093/jac/dkm453
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Research letters |
Emergence of Candida tropicalis resistant to caspofungin
1 Summa Health System, 75 Arch Street, Akron, OH 44304, USA 2 University Case Medical Center, 11100 Euclid Avenue, LKS 5028, Cleveland, OH 44106, USA
* Corresponding author. Tel: +1-206-3727047; Fax: +1-330-3756608; E-mail: jonrupert@gmail.com
Keywords: echinocandins , invasive candidiasis , candidal oesophagitis
| The first 10% of the full text of this article appears below. |
Sir,
Candida species is the fourth leading cause of nosocomial bloodstream infection in the USA. The incidence and mortality of invasive candidiasis (IC) remain high despite new antifungal agents. Although Candida albicans remains the most common isolated species causing IC, the
| Funding |
|---|
| Transparency declarations |
|---|